PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention

The summary for the PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention - ERA, which is the U.S. government agency offering this grant.

PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention: The purpose of this notice of funding opportunity (NOFO) is to support an implementation research study. In this study, optimal strategies will be assessed for a postexposure prophylaxis (PEP) in pocket (PiP) approach for prevention of HIV and sexually transmitted infections (STIs) among disproportionately affected populations, for example, gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW). The recipient will implement and evaluate a comprehensive strategy to integrate PEP packs as a component of existing PrEP and STI clinical services. PEP packs will include a supply of antiretroviral medication for nonoccupational PEP (nPEP), doxycycline for STI PEP (DoxyPEP), HIV and STI self-test kits, and instruction materials. Study clinics should be in communities with high rates of HIV diagnoses among disproportionately affected populations, for example, Black and Hispanic MSM and TGW.

Federal Grant Title:	PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
Federal Agency Name:	Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-25-112
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.084
CFDA Descriptions:	Information not provided
Current Application Deadline:	February 19th, 2025
Original Application Deadline:	February 19th, 2025
Posted Date:	December 13th, 2024
Creation Date:	December 13th, 2024
Archive Date:	March 21st, 2025
Total Program Funding:	$4,800,000
Maximum Federal Grant Award:	$1,200,000
Minimum Federal Grant Award:	$900,000
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	December 13th, 2024

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: N/A
Grant Announcement Contact: Jocelyn Patterson Mosley
[email protected]
[email protected]
Similar Government Grants: • Modeling Infectious Diseases in Healthcare (MInD Healthcare) to Improve Pathogen Preventio...; • Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico; • Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Ot...; • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...; • Impact of Japanese Encephalitis Vaccination in Cambodia; • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...; • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention - ERA: • Extension of the World Trade Center Health Registry (U50); • Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico; • NIOSH Underground Mine Evacuation Technologies and Human Factors Research; • Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Ot...; • Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Co...